Warberg Asset Management’s Entera Bio Ltd. Warrant ENTXW Stock Holding History

Warberg Asset Management’s Portfolio ENTXW Stock Details ENTXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14,047	Closed	-$4K	–	264
2021 Q4	$4K	Sell	14,047 -30,954	-69%	-$13.8K	﹤0.01%	200
2021 Q3	$23K	Hold	45,001	–	–	﹤0.01%	182
2021 Q2	$45K	Buy	45,001 +9,744	+28%	+$4.76K	0.01%	175
2021 Q1	$18K	Sell	35,257 -253,468	-88%	-$88.1K	0.01%	148
2020 Q4	$25K	Buy	+288,725	New	+$36.2K	0.01%	139

Other funds holding ENTXW

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Warberg Asset Management's ENTXW Position: Q1 2022 in Review

Warberg Asset Management sold out of Entera Bio Ltd. Warrant (ENTXW) in Q1 2022, closing a stake of 14,047 shares — an estimated $4K sold.

Warberg Asset Management first reported a position in ENTXW in Q4 2020 and held it in 5 quarters. The position peaked at $45K in Q2 2021. 3 funds tracked by Wall St. Rank hold ENTXW as of Q1 2022.

Warberg Asset Management reported no remaining Entera Bio Ltd. Warrant position as of Q1 2022 after selling out during the quarter.
Warberg Asset Management sold 14,047 Entera Bio Ltd. Warrant shares in Q1 2022, an estimated $4K.
Warberg Asset Management first reported a position in Entera Bio Ltd. Warrant in Q4 2020 and held it in 5 quarters.
Warberg Asset Management's Entera Bio Ltd. Warrant position peaked at $45K in Q2 2021.
3 funds tracked by Wall St. Rank held Entera Bio Ltd. Warrant as of Q1 2022.

Based on Warberg Asset Management's 13F filing for Q1 2022, filed 13 May 2022.